Acura Pharmaceuticals Announces Executive Leadership Transition

Acura Pharmaceuticals (ACUR) has shared an update.

Peter A. Clemens, Sr. Vice President and CFO of Acura Pharmaceuticals, is set to retire on September 30, 2024, with a planned transition period until then. Robert A. Seiser, with the company since 1998 and currently its VP Treasurer and Corporate Controller, will succeed Clemens as the new CFO starting August 1, 2024. This executive shift marks a significant change in Acura’s financial leadership.

See more insights into ACUR stock on TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.